This can explain CaM’s role in KRAS-driven cancers (Nussinov et al. 2017b), in line with genetically-engineered mouse models showing that oncogenic KRas can induce senescence or proliferation and differentiation (Xu et al. 2014), but is unable to induce full PI3Kα activation. This evidence concerns the gene KRAS and cancer.